China-US drugmaker JOINN Biologics raises $150m in Series B led by CPE

China-US drugmaker JOINN Biologics raises $150m in Series B led by CPE

Visuals from JOINN Biologics' website.

06 August, 2021

CDMO CPE CRO JOINN Biologics JOINN Laboratories pharmaceutical

Printed by Unregistered user on Sun, 13 Jul 2025 14:10:03 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Hillhouse backs $150m round in HK-listed MicroPort's heart rhythm management unit

Venture Capital

Chinese drug discovery firm BioMap bags $100m Series A led by GGV Capital

Read more from Greater China

Editor’s Take: The Week That Was—July 7-12

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies